|
시장보고서
상품코드
2009094
실험실 장비 및 소모품 시장 보고서 : 제품 유형별, 최종 용도별, 지역별(2026-2034년)Laboratory Equipment and Disposables Market Report by Product Type (Equipment, Disposables), End Use (Hospitals, Laboratories, and Others), and Region 2026-2034 |
||||||
세계의 실험실 장비 및 소모품 시장 규모는 2025년에 432억 달러에 달했습니다. 향후 IMARC Group은 2034년까지 시장 규모가 753억 달러에 달하고, 2026년부터 2034년까지 CAGR 6.17%로 성장할 것으로 예측했습니다. 첨단 기술의 통합, 정부 주도의 여러 정책 시행, 진단 및 맞춤형 의료를 포함한 의료 분야의 현저한 확대 등 다양한 요인이 시장을 주도하고 있습니다.
의료 분야 확대
의료 분야, 특히 진단 및 개인화 의료 분야에서 시장이 크게 성장하고 있습니다. 의료기술의 발전으로 하이스루풋 시퀀서, 첨단 영상 진단 시스템 등 최첨단 진단 도구가 등장해 진단의 방식을 바꾸고 있습니다. 이는 보다 신속하고 정확한 질병 감지를 가능하게 하며, 시장에 영향을 미치고 있습니다. 이러한 기술은 시료 전처리 키트에서 특수 진단 시약에 이르기까지 다양한 실험실 장비 및 소모품에 의존하고 있으며, 이는 이러한 도구에 대한 수요를 촉진하고 있습니다. 또한, 맞춤형 의료는 환자의 유전자 구성, 생활습관, 기타 요인에 따라 치료를 개별적으로 최적화하는 것으로, 분자진단, 유전자 검사, 바이오마커 분석에 크게 의존하기 때문에 실험실 장비 및 소모품에 대한 수요가 증가하고 있습니다. 이와 더불어, 대량 검사를 효율적으로 처리하고 자동화 및 고처리량 검사로 전환하기 위해 의료 시스템에서 실험실 장비 및 소모품의 채택이 증가하고 있는 것도 시장 성장을 촉진하고 있습니다. 2023년 1월 13일, 지멘스 헬시니어스(Siemens Healthineers)는 아일랜드 Swords에 '면역측정 기기 연구 개발(R&D) 우수 센터'를 설립했습니다. 이 새로운 센터는 감염성 질환, 암, 혈액 질환을 감지하는 데 사용되는 검사 장비의 획기적인 혁신을 실현하는 데 초점을 맞출 예정입니다. 전 세계에 의료 진단 기기를 공급하고 있는 기존 제조 및 엔지니어링 거점에는 지멘스 헬시니어스가 수백만 유로 규모의 투자를 진행할 예정입니다.
새로운 기술 발전
과학 연구 및 실험 분야에서는 시장에 변화를 가져올 수 있는 새로운 기술 발전의 물결이 밀려오고 있습니다. 이러한 혁신은 정확성, 효율성 및 데이터 정확도를 향상시킬 수 있으며, 이는 실험실 장비 및 소모품 시장의 성장을 뒷받침하고 있습니다. 또한, 검사 워크플로우에 자동화 및 로봇 기술의 통합이 진행되고 있습니다. 자동화 시스템은 반복적인 작업을 정확하게 수행할 수 있기 때문에 인위적인 실수를 줄이고 처리 능력을 향상시킬 수 있습니다. 이를 통해 연구를 가속화할 뿐만 아니라, 특히 민감한 실험에서 오염의 위험을 최소화할 수 있습니다. 또한, 미세유체 장치의 도입으로 연구자들은 더 작은 규모의 실험을 할 수 있게 되어 귀중한 시료와 시약을 절약할 수 있습니다. 이를 통해 실험 파라미터를 보다 세밀하게 제어할 수 있으며, 신약개발부터 데옥시리보핵산(DNA) 분석에 이르기까지 다양한 용도로 활용할 수 있습니다. 또한, 데이터 분석과 인공지능(AI)의 통합을 통해 실험 장비에서 생성된 방대한 데이터세트를 분석하여 패턴과 발견을 식별할 수 있습니다. 2024년 4월 1일, 애질런트 테크놀러지스(Agilent Technologies Inc.)는 생산성 향상, 총소유비용 절감 및 실험실 전반의 효율성 향상을 지원하는 새로운 자동화 워크플로우 솔루션인 첨단 희석 시스템인 ADS 2를 발표했습니다. Agilent ADS 2는 실험실 워크플로우를 강화하기 위해 설계된 지능형 자동 희석 장치입니다.
정부의 노력
각국 정부 기관은 과학 연구 촉진부터 의료 서비스의 품질과 안전성 확보에 이르기까지 다양한 노력을 기울이고 있습니다. 이는 장비의 안전과 품질을 보장하기 위한 규제 조치를 시행하는 것입니다. 이러한 규제에는 제품 품질, 성능 및 안전 기준이 포함됩니다. 이와 더불어, 정부 주도의 혁신 프로그램, 세제 혜택, 연구 보조금은 새로운 실험실 기술 및 솔루션 개발을 촉진하고, 그 결과 혁신적인 제품이 시장에 출시되어 연구 전문가와 의료 서비스 제공자의 관심을 끌고 있습니다. 또한, 정부 당국은 의료 및 생명과학을 포함한 다양한 분야의 연구개발(R&D) 활동을 지원하기 위해 예산을 배정하고 있습니다. 이 자금에는 종종 연구 기관이 첨단 실험실 장비와 소모품을 구입할 수 있도록 지원하는 보조금과 보조금이 포함되어 있습니다. 예를 들어, 2023년 7월 27일, 캐나다 정부 기관과 JDRF Canada는 공동으로 당뇨병의 예방, 감지, 관리, 치료를 위한 12개의 연구 프로젝트에 3,300만 달러를 투자했습니다. 4개 연구팀은 1형 당뇨병의 정밀의학(Precision Medicine)을 연구하여 각 환자의 특정 요구에 맞는 당뇨병 치료를 제공하고, 베타세포 집단 내 다양성을 조사할 예정입니다.
The global laboratory equipment and disposables market size reached USD 43.2 Billion in 2025. Looking forward, IMARC Group expects the market to reach USD 75.3 Billion by 2034, exhibiting a growth rate (CAGR) of 6.17% during 2026-2034. There are various factors that are driving the market, which include the integration of advanced technologies, the implementation of several government initiatives, and the significant expansion in the healthcare sector including diagnostics and personalized medicine.
Expansion in Healthcare Sector
The market is witnessing substantial growth in the healthcare sector, particularly in the field of diagnostics and personalized medicine. Several advancements in healthcare technology are transforming diagnostics with the advent of cutting-edge diagnostic tools such as high-throughput sequencers and advanced imaging systems, which enable quicker and more accurate disease detection, thereby influencing the market. These technologies rely on laboratory equipment and disposables, ranging from sample preparation kits to specialized diagnostic reagents, which is catalyzing the demand for these tools. Moreover, personalized medicine tailors treatments to individual patients based on their genetic makeup, lifestyle, and other factors, relying heavily on molecular diagnostics, genetic testing, and biomarker analysis, thereby increasing laboratory equipment and disposables demand. Besides this, the rising adoption of laboratory equipment and disposables in the healthcare systems to process a large volume of tests efficiently and shift toward automation and high-throughput testing is bolstering the market growth. On 13 January 2023, Siemens Healthineers launched a Center of Excellence for Immunoassay Instrument Research and Development (R&D) in Swords, Ireland. The new center will focus on unlocking breakthrough innovations in laboratory instruments used to detect infectious diseases, cancer, and blood disorders. The existing manufacturing and engineering site, which supplies medical diagnostic equipment globally, will receive a multi-million-euro investment from Siemens Healthineers.
Emerging Technological Advancements
The market is witnessing a transformative wave of emerging technological advancements in scientific research and experimentation. These innovations can enhance precision, efficiency, and data accuracy, which is supporting the laboratory equipment and disposables market growth. In addition, there is a rise in the integration of automation and robotics into laboratory workflows. Automated systems can perform repetitive tasks with precision, thereby reducing human error and increasing throughput. This also accelerates research and minimizes the risk of contamination, particularly in sensitive experiments. Besides this, the introduction of microfluidic devices allows researchers to conduct experiments on a much smaller scale, conserving valuable samples and reagents that offer greater control over experimental parameters and can be used in applications ranging from drug discovery to deoxyribonucleic acid (DNA) analysis. Additionally, the integration of data analytics and artificial intelligence (AI) analyzes vast datasets generated by laboratory equipment and identifies patterns and insights. On 1 April 2024, Agilent Technologies Inc. introduced its advanced dilution system, the ADS 2, a new automation workflow solution that will assist in increasing productivity, lowering cost of ownership, and improving the overall efficiency within the laboratory. The Agilent ADS 2 is an intelligent autodilutor designed to enhance laboratory workflows.
Government Initiatives
Governing agencies of various countries are undertaking several initiatives, ranging from promoting scientific research to ensuring the quality and safety of healthcare services. They are implementing regulatory initiatives to ensure the safety and quality of equipment. These regulations include product quality, performance, and safety standards. Along with this, government-sponsored innovation programs, tax incentives, and research grants encourage the development of new laboratory technologies and solutions resulting in the introduction of novel products in the market, attracting the attention of research professionals and healthcare providers . Moreover, governing authorities are allocating budgets to support research and development (R&D) activities in various fields, including healthcare and life sciences. This funding often includes grants and subsidies that enable research institutions to acquire advanced laboratory equipment and disposables. For instance, on 27 July 2023, the governing agencies in Canada and JDRF Canada jointly invested US$ 33 Million in 12 research projects that will work to prevent, detect, manage, and treat diabetes. Four research teams will work on precision medicine in type 1 diabetes to tailor diabetes care to each patient's specific needs and investigate the diversity within beta cell populations.
Equipment accounts for the majority of the market share
Incubators and other related equipment help to maintain precise ambient conditions and temperatures for investigations involving cell growth and microbiology. Additionally, micro manipulation systems enable precise procedures at the microscale, enabling genetic engineering and cell research, and laminar flow hoods provide a sterile workspace by directing filtered air to prevent contamination, thus offering a positive laboratory equipment and disposables market outlook. Additionally, lab air filtration systems guarantee a sterile and controlled laboratory environment, and centrifuges are essential for separating components in biological samples.
Hospitals hold the largest share of the industry
Hospitals are the primary providers of comprehensive medical services. They require an extensive array of laboratory equipment for diagnostic purposes including blood analyzers, centrifuges, and diagnostic imaging systems like magnetic resonance imaging (MRI) and computed tomography (CT) scanners that aid in the accurate diagnosis of diseases and enable timely treatment. Moreover, hospitals have a constant need for disposable items such as syringes, test tubes, and medical gloves, thus representing another major growth-inducing factor. These disposables are essential for maintaining strict hygiene standards and preventing the spread of infections within a hospital environment. Along with this, the rising focus on infection control is leading to the demand for disposables in healthcare settings.
North America leads the market, accounting for the largest laboratory equipment and disposables market share
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for laboratory equipment and disposables.
The presence of world-renowned research institutions, universities, and pharmaceutical companies in the North America region is impelling the market growth. These organizations rely on advanced laboratory equipment and disposables to conduct cutting-edge research, drive innovation, and develop new products. Moreover, several technological advancements in the field of laboratory equipment are introduced to create advanced, user-friendly, and precise laboratory instruments to meet local demands and attract international buyers. Apart from this, favorable government initiatives in the region are bolstering the market growth. For example, on 7 March 2023, Washington University School of Medicine in St. Louis positioned to NO.2 in nation due to National Institutes of Health (NIH) research funding. This ranking reflects the school's commitment to cutting-edge research and positions it as a key player in shaping the future of medicine.
Key players in the market are actively taking strategic measures to strengthen their positions in the industry. These actions are a response to the competitive landscape and the evolving needs of end users. Companies are investing in R&D to introduce innovative and technologically advanced products including the development of precise and efficient laboratory equipment, disposables with enhanced features, and automation solutions that streamline laboratory processes to increase their laboratory equipment and disposables market revenue. Moreover, companies are forming strategic partnerships and collaborations with research institutions, universities, and other industry players, which facilitate knowledge exchange, access to new technologies, and the development of customized solutions. Apart from this, market players are expanding their presence globally by establishing subsidiaries or acquiring local companies in emerging markets to serve individuals across the globe. On 4 April 2024, Shimadzu Medical Systems USA (SMS), a medical division of Shimadzu Precision instruments, Inc., acquired California X-ray Imaging Services, Inc. (CIS) to further expand its Healthcare Business in North America.